Skip to main content
Equibles
SSII logo

SSII · SS Innovations International, Inc. · Metrics

Track SSII — free

Use SSII with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SSII.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.41 -0.13 (-5.12%) At close · Oct 21
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These conditions raise substantial doubt about our ability to continue as a going concern.”
View the 10-Q filed Aug 13, 2026
Market Cap
$508.98M
Shares
200.39M
Volume · Oct 21 25.54K Avg daily vol (3M) 63.38K

SSII metrics

87 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.41
Market cap
$508.98M

Price action

20 metrics
Price change (1W)
-0.4%
Price change (30D)
-22.8%
Price change (3M)
-29.1%
Price change (6M)
-44.8%
Price change (YTD)
-55.3%
Price change (1Y)
-74.5%
Trailing year
Price change (5Y)
—
52-week high
$9.98
52-week low
$2.45
Change from 52-week high
-74.5%
Change from 52-week low
+3.7%
Annualized volatility
80.1%
Annualized volatility (3M)
50.7%
Beta
0.7
RSI (14D)
34.6
Price vs SMA 50
-19.9%
Price vs SMA 200
-36.6%
Avg volume (3M)
63,610
Relative volume
0.3
Average dollar volume
$211,110

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
200.39M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
9.7×
reciprocal yield 10.3%
EV / EBITDA
—
EV / EBIT
—
P / sales
9.7×
reciprocal yield 10.3%
P / book
9.5
reciprocal yield 10.5%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-2.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
45.8×
reciprocal yield 2.2%
EV / revenue historical average (5Y)
45.8×
reciprocal yield 2.2%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2025-10-28

Profitability

9 metrics
Gross margin
47.6%
Operating margin
-15.8%
Trailing 12 months
Net margin
-23.7%
Gross profit (TTM)
$24.97M
Operating profit (TTM)
−$8.28M
Net income (TTM)
−$12.43M
Trailing 12 months
Diluted EPS (TTM)
$-0.06
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.26
Gross profit per diluted share (TTM)
$0.12
Operating profit per diluted share (TTM)
$-0.04
EBITDA per diluted share (TTM)
$-0.03
Net income per diluted share (TTM)
$-0.06
Operating cash flow per diluted share (TTM)
$-0.08
Free cash flow per diluted share (TTM)
$-0.09
Capital expenditures per diluted share (TTM)
$0.01
R&D per diluted share (TTM)
$0.03
Stock compensation per diluted share (TTM)
$0.05
Book value per share
$0.20

Growth

11 metrics
Revenue growth YoY
+39.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
$52.40M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.2%
Year over year · more shares
Revenue CAGR (3Y)
+209.3%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-23.3%
Return on assets
-12.8%
Debt / equity
0.3
Current ratio
2.2
EBITDA (TTM)
−$7.00M
Free cash flow (TTM)
—
Quick ratio
1.7
Interest coverage
-7.3
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$987,530
Latest balance sheet
Cash & equivalents
$13.65M
Total assets
$96.98M
Total debt
$14.63M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$15.53M
Capital expenditures (TTM)
$2.84M
R&D (TTM)
$5.57M
SG&A (TTM)
$16.96M
Stock compensation (TTM)
$9.44M
R&D / revenue
10.6%
Stock compensation / revenue
18.0%

Ownership (13F)

9 metrics
13F filers
23
13F filer change QoQ
-3
Institutional ownership
0.8%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
0.5%
Private-fund adviser ownership
0.5%
Active holders' share change QoQ
-7.3%
Holder tenure
2.9
Price vs estimated holder cost
-24.4%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.1%

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
30 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$99,999
Insider-sentiment score
48 / 100

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1676163 CUSIP 05453U203 13F (30d) 4 filings 4 filers Visit website Investor relations